CellSeed (TSE:7776) Operating Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7776 CellSeed Inc TSE:7776
55 GF Score
Price 円226.00
GF Value 円162.45
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is CellSeed Operating Margin %?

CellSeed TSE:7776 +0.44% 55 Operating Margin % is 0.00% as of Dec. 2025. GuruFocus rates TSE:7776 with a GF Score™ of 55/100 and a GF Value™ of 円162.45 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 939 Biotechnology companies, CellSeed ranks worse than 84.56% on this metric.

Operating Margin % is calculated as Operating Income divided by its Revenue. CellSeed's Operating Income for the three months ended in Dec. 2025 was 円0.00 Mil. CellSeed's Revenue for the three months ended in Dec. 2025 was 円0.00 Mil. Therefore, CellSeed's Operating Margin % for the quarter that ended in Dec. 2025 was 0.00%.

Warning Sign:

CellSeed Inc operating margin has been in a 5-year decline. The average rate of decline per year is -15.8%.

The historical rank and industry rank for CellSeed's Operating Margin % or its related term are showing as below:

TSE:7776' s Operating Margin % Range Over the Past 10 Years
Min: -2017.71   Med: -486.2   Max: 13.65
Current: -2017.71


TSE:7776's Operating Margin % is ranked worse than
84.56% of 939 companies
in the Biotechnology industry
Industry Median: -86.77 vs TSE:7776: -2017.71

CellSeed's 5-Year Average Operating Margin % Growth Rate was -15.80% per year.

CellSeed's Operating Income for the three months ended in Dec. 2025 was 円0.00 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was 円-481.00 Mil.


CellSeed  (TSE:7776) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


CellSeed Operating Margin % Related Terms


CellSeed Operating Margin % Historical Data

* Premium members only.

The historical data trend for CellSeed's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CellSeed Operating Margin % Chart

CellSeed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -534.48 -587.86 -366.99 -437.91 -1,250.18

CellSeed Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,464.10 -2,265.26 0.00 0.00 -1,833.12

TSE:7776 vs VRTX, REGN, ALNY: Operating Margin % Comparison

For the Biotechnology subindustry, CellSeed's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellSeed Operating Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellSeed's Operating Margin % distribution charts can be found below:

* The bar in red indicates where CellSeed's Operating Margin % falls into.


TSE:7776
55GF Score
CellSeed Inc TSE:7776
Operating Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CellSeed Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

CellSeed's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=-1046.127 / 83.678
=-1,250.18 %

CellSeed's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=0 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Margin % →
What does a Operating Margin % of 0.00% mean?
CellSeed (TSE:7776) has a Operating Margin % of 0.00% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on CellSeed and its competitors. According to the industry distribution chart, CellSeed ranks #794 out of 939 companies in the Biotechnology industry, placing it in the top 84.6%.
Is CellSeed's Operating Margin % too high?
CellSeed's current Operating Margin % is 0.00%. Based on the distribution chart, CellSeed ranks #794 out of 939 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, CellSeed has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CellSeed's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CellSeed ranks #794 out of 939 companies for Operating Margin %. This places CellSeed in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on CellSeed and its competitors. CellSeed's current Operating Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellSeed stock overvalued right now?
Based on GuruFocus' analysis, CellSeed (TSE:7776) is currently considered Significantly Overvalued. The stock's GF Value™ is 円162.45, compared to a current price of 円226.00 — trading 39.1% above its estimated fair value. The current Operating Margin % is 0.00%. CellSeed's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For CellSeed (TSE:7776), the current Operating Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CellSeed (TSE:7776) Overvalued in 2026?

Based on GuruFocus' analysis, CellSeed stock appears to be overvalued. The current stock price of 円226.00 is trading 39.1% above its estimated GF Value™ of 円162.45. GuruFocus considers CellSeed to be Significantly Overvalued.

Key valuation signals for TSE:7776:

  • Operating Margin %: 0.00%
  • GF Value™: 円162.45 vs. price of 円226.00 (39.1% above fair value)
  • GF Score™: 55/100 with 4 warning signs

No single metric tells the full story. See the TSE:7776 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CellSeed Business Description

Address 2-5-10 Aomi, Telecom Center Building, 15th Floor (East Wing, Koto-ku, Tokyo, JPN, 135-0064
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheets for corneal and esophageal regeneration; regenerated cardiac patches to treat heart diseases; cell sheets for periodontal tissue regeneration; and regenerated cartilage sheets for the treatment of osteoarthritis.
55GF Score

Get the complete analysis for TSE:7776

Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円226.00
Price
円162.45
GF Value